D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Emerson Electric
EMR
|
+$577M |
| 2 |
Amazon
AMZN
|
+$538M |
| 3 |
Tesla
TSLA
|
+$501M |
| 4 |
Netflix
NFLX
|
+$352M |
| 5 |
Adobe
ADBE
|
+$342M |
Top Sells
| 1 |
Alibaba
BABA
|
+$945M |
| 2 |
NVIDIA
NVDA
|
+$485M |
| 3 |
CELG
Celgene Corp
CELG
|
+$460M |
| 4 |
ConocoPhillips
COP
|
+$344M |
| 5 |
Biogen
BIIB
|
+$322M |
Sector Composition
| 1 | Technology | 20.59% |
| 2 | Consumer Discretionary | 15.86% |
| 3 | Healthcare | 13.39% |
| 4 | Financials | 10.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Kearny Financial
KRNY
$421M
| $4.31M | ﹤0.01% |
311,937
+54,267
| +21% | +$750K |
|
1202
Magnite
MGNI
$3.44B
| $4.31M | ﹤0.01% |
527,617
-85,316
| -14% | -$696K |
|
1203
RingCentral
RNG
$2.83B
| $4.31M | ﹤0.01% |
25,521
-383,696
| -94% | -$64.7M |
|
1204
Markel Group
MKL
$24.8B
| $4.3M | ﹤0.01% |
3,762
-1,150
| -23% | -$1.31M |
|
1205
Regis Corp
RGS
$69.1M
| $4.29M | ﹤0.01% |
12,008
-6,896
| -36% | -$2.46M |
|
|
EGRX
1206
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $4.29M | ﹤0.01% |
71,392
-16,384
| -19% | -$984K |
|
1207
Hilton Grand Vacations
HGV
$4.07B
| $4.28M | ﹤0.01% |
+124,423
| New | +$4.28M |
|
|
KBAL
1208
DELISTED
Kimball International
KBAL
| $4.28M | ﹤0.01% |
206,780
-11,585
| -5% | -$240K |
|
1209
Stellantis
STLA
$27.6B
| $4.27M | ﹤0.01% |
290,883
-559,765
| -66% | -$8.22M |
|
1210
Peabody Energy
BTU
$2.25B
| $4.26M | ﹤0.01% |
466,986
-106,914
| -19% | -$975K |
|
1211
Dorian LPG
LPG
$1.35B
| $4.25M | ﹤0.01% |
274,439
+170,925
| +165% | +$2.65M |
|
1212
UMB Financial
UMBF
$9.24B
| $4.24M | ﹤0.01% |
61,706
+4,009
| +7% | +$275K |
|
1213
Sandstorm Gold
SAND
$3.44B
| $4.22M | ﹤0.01% |
566,242
-3,221
| -0.6% | -$24K |
|
1214
HEICO
HEI
$44.7B
| $4.22M | ﹤0.01% |
36,983
-31,645
| -46% | -$3.61M |
|
1215
Acadia Healthcare
ACHC
$2.06B
| $4.22M | ﹤0.01% |
+127,024
| New | +$4.22M |
|
1216
PPG Industries
PPG
$25.2B
| $4.21M | ﹤0.01% |
31,551
+4,162
| +15% | +$556K |
|
1217
Trinseo
TSE
$87.4M
| $4.21M | ﹤0.01% |
113,043
-32,606
| -22% | -$1.21M |
|
1218
Standard BioTools
LAB
$508M
| $4.2M | ﹤0.01% |
1,207,185
+119,310
| +11% | +$415K |
|
1219
Lands' End
LE
$467M
| $4.2M | ﹤0.01% |
249,714
+85,660
| +52% | +$1.44M |
|
1220
TriMas Corp
TRS
$1.59B
| $4.19M | ﹤0.01% |
133,356
-17,110
| -11% | -$537K |
|
1221
Cenovus Energy
CVE
$30.4B
| $4.17M | ﹤0.01% |
410,198
-1,795,951
| -81% | -$18.2M |
|
1222
EPR Properties
EPR
$4.31B
| $4.17M | ﹤0.01% |
+58,970
| New | +$4.17M |
|
1223
SPDR S&P Biotech ETF
XBI
$5.52B
| $4.16M | ﹤0.01% |
43,690
| – | – |
|
1224
Skyworks Solutions
SWKS
$11.1B
| $4.15M | ﹤0.01% |
34,347
+8,497
| +33% | +$1.03M |
|
1225
Wabash National
WNC
$472M
| $4.15M | ﹤0.01% |
282,622
-31,030
| -10% | -$456K |
|